4/29/2014 10:34:44 AM
Bristol-Myers Squibb Company (NYSE:BMY) today reported financial results for the first quarter of 2014 and adjusted GAAP and non-GAAP guidance for 2014. The first quarter was highlighted by the achievement of important regulatory milestones for Eliquis, daclatasvir/asunaprevir and the diabetes franchise. The company also completed the sale of its diabetes business to AstraZeneca, receiving $3.3 billion in closing and milestone payments during the quarter.
Help employers find you! Check out all the jobs and post your resume.
comments powered by